The injection of methadone syrup in New South Wales: Patterns of use and increased harm after partial banning of injecting equipment

Australian and New Zealand Journal of Public Health

Volumn 27, Issue 5, 2003, Pages 551-555

  Hopwood, Max ^a   Southgate, Erica ^a   Kippax, Susan ^a   Bammer, Gabriele ^b   Isaac Toua, Geetha ^b   MacDonald, Margaret ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; CLINICAL PRACTICE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MONITORING; DRUG USE; FEMALE; HEALTH CARE POLICY; HEALTH HAZARD; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; NEEDLE; OPIATE ADDICTION; PREVALENCE; RISK ASSESSMENT; SEX DIFFERENCE; SYRINGE; SYRUP;

EID: 0142124237     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.2003.tb00832.x     Document Type: Article

References (17)

1. Darke S, Ross J, Hall W. The Injection of Methadone Syrup in Sydney Australia. Sydney: National Drug and Alcohol Research Centre; 1995.
2. Darke S, Ross J, Kaye S. Physical injecting sites among injecting drug users in Sydney, Australia. Drug Alcohol Depend 2001;62:77-82.
3. MacDonald M, Evers A, Wodak A, Kaldor J. Prevalence of HCV antibody among methadone injectors in Australia. Proceedings of the 2nd Australasian Conference on Hepatitis C: 'HCV - The Evolving Epidemic; 1999, Christchurch, New Zealand.
4. Sunjic S, Howard J. "Non-injectables": Methadone syrup and benzodiazepine injection by methadone-maintained clients. Drug Alcohol Rev 1996;15:245-50.
5. Lintzeris N, Lenne M, Ritter A. Methadone injecting in Australia: A tale of two cities. Addiction 1999;94(8):1175-8.
6. Loxley W, Carruthers S, Bevan J. In the Same Vein: First Report of the Australian Study of HIV and Injecting Drug Use. Perth: National Centre for Research into the Prevention of Drug Abuse, Curtin University of Technology; 1995.
7. MacDonald MA, Wodak AD, Dolan KA, Van Beek I, Cunningham PH, Kaldor JM. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Med J Aust 2000;172:57-61.
8. MacDonald M, Crofts N, Kaldor J. Transmission of hepatitis C virus: Rates, routes and cofactors. Epidemiol Rev 1996;18:137-47.
9. Felder C, Uehlinger C, Baumann P, Powell K, et al. Oral and intravenous methadone use: Some clinical and pharmacokinetic aspects. Drug Alcohol Depend 1999;55:137-43.
10. Donoghoe MC, Wodak A. Health and social consequences of injecting drug use. In: Stimson GV, Des Jarlais DC, Ball AL, editors. Drug Injecting and HIV Infection: Global Dimensions and Local Responses. London: UCL Press; 1998.
11. Strang J, Bearn J, Farrell M, Finch E, et al. Route of drug use and its implications for drug effect, risk of dependence and health consequence. Drug Alcohol Rev 1998;17:197-211.
12. Debattista J. The Distribution of Surflos Winged Infusion Sets Through Needle Exchange Outlets [discussion paper]. Brisbane: Community Alcohol and Drug Services, Brisbane North Regional Health Authority; 1992.
13. Southgate E, Hopwood M. Injecting Drug Use and Risk [Drug Use and Gay men issue paper]. Sydney: National Centre in HIV Social Research; 1999.
14. Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996-2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev 2002;21(1):27-32.
15. Leavitt SB, Shinderman M, Maxwell S, Eap CB, Paris P. When "enough" is not enough: New perspectives on optimal methadone maintenance dose. Mt. Sinai J Med 2000;67(5-6):404-11.
16. Metrebian N, Shanahan W, Stimson GV, Small C, Lee M, Mtutu V, Wells B. Prescribing drug of choice to opiate dependent drug users: A comparison of clients receiving heroin with those receiving injectable methadone at a West London drug clinic. Drug Alcohol Rev 2001;20(3):267-76.
17. Metrebian N, Shanahan W, Wells B, Stimson GV. Feasibility of prescribing injectable heroin and methadone to opiate-dependent drug users: Associated health gains and harm reductions. Med J Aust 1998;168:596-600.